share_log
Breakings ·  Nov 8 05:05

Nov 07 (Reuters) - Adaptive Biotechnologies Q3 Revenue USD 46.435 Million Vs. IBES Estimate USD 40.2 Million.

  • Q3 Operating Income USD -32.632 Million Vs. IBES Estimate USD -43.2 Million
  • Q3 Net Income USD -32.097 Million Vs. IBES Estimate USD -43.9 Million
  • Q3 Operating Expenses USD 79.067 Million
  • Q3 Adjusted Ebitda USD -14.3 Million Vs. IBES Estimate USD -23.6 Million
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated